As artificial intelligence infrastructure expands at pace, the insurance risks surrounding global data centres are growing increasingly complex and harder to manage. Large lawsuits involving data centres more than tripled from four
Alembic Pharmaceuticals has received a formal warning letter from the U.S. Food and Drug Administration targeting its bioequivalence research facility in Vadodara, India. The warning letter, dated July 10, 2026, follows an
More
Representative Rich McCormick, a Republican from Georgia, introduced the Biotechnology Diplomacy Leadership Act on July 16, 2026, formally designated as H.R. 9755. The bill aims to strengthen America’s position in what is
More
Skadden Arps faces mounting political pressure over its conflict of interest concerns tied to its deal with the Trump administration and its simultaneous legal work for Intel. Senators Richard Blumenthal and Adam
More
Generic drugs imported into the United States will face zero tariffs for two years starting August 1, before sharply escalating levies take hold, President Donald Trump has announced. Trump said a 100%
More
European private equity giant EQT has announced a partnership with Sir Ben Ainslie’s SailGP team, Emirates GBR, ahead of this weekend’s British leg of the series. The Swedish global investment firm, which
More
On 20 July 2026, Judge R. Gary Klausner of the Central District of California declared Vivek Shah a vexatious litigant in a significant privacy law ruling. The decision came in the case
More
Ninth Circuit Judge Lawrence VanDyke has drawn sharp criticism after filing a dissent that urged the Supreme Court to summarily reverse his own court’s Second Amendment rulings. The dissent came in the
More
Wall Street saw a significant rally as the Dow Jones Industrial Average surged approximately 300 points, lifted by a wave of positive investor sentiment. General Motors (GM) provided one of the session’s
More
The abolition of the Department of Science, Innovation and Technology has drawn swift criticism from peers, industry groups and former advisers within hours of the announcement. Ministers were summoned before the House
More
Novo Nordisk (NVO) Sues Eli Lilly (LLY) Over Allegedly Misleading Zepbound And Mounjaro Ad Campaigns
Novo Nordisk has filed a federal lawsuit against Eli Lilly and Company and Lilly USA, LLC over national advertising campaigns for two of its flagship weight-loss drugs. The suit was filed in
More